Showing 1 - 6 of 6 Items
Showing 1 - 6 of 6 Items
Sort By: Relevance
Journal Article
|Research
2021-02-18 • PLOS One
2021-02-18 • PLOS One
BACKGROUND
Childhood and adolescent drug-resistant TB (DR-TB) is one of the neglected infectious diseases. Limited evidence exists around programmatic outcomes of children and adoles...
Childhood and adolescent drug-resistant TB (DR-TB) is one of the neglected infectious diseases. Limited evidence exists around programmatic outcomes of children and adoles...
Journal Article
|Research
2021-03-10 • PLOS One
2021-03-10 • PLOS One
Background: Childhood multidrug-resistant TB (MDR-TB) still affects around 25000 children every year across the globe. Though the treatment success rates for drug-resistant TB (DR-TB) in...
Journal Article
|Research
2020-05-05 • PLOS One
2020-05-05 • PLOS One
BACKGROUND
Routine viral-load (VL) measurements along with enhanced adherence counselling (EAC) are recommended to achieve virological suppression among people living with HIV/AIDS (...
Routine viral-load (VL) measurements along with enhanced adherence counselling (EAC) are recommended to achieve virological suppression among people living with HIV/AIDS (...
Conference Material
|Slide Presentation
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
Conference Material
|Abstract
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
INTRODUCTION
Drug-resistant TB (DR-TB) still affects around 25,000 children every year worldwide. Although treatment success rates for DR-TB in children are higher than in adults, ch...
Drug-resistant TB (DR-TB) still affects around 25,000 children every year worldwide. Although treatment success rates for DR-TB in children are higher than in adults, ch...
Journal Article
|Research
2020-12-01 • International Journal of Tuberculosis and Lung Disease
2020-12-01 • International Journal of Tuberculosis and Lung Disease
SETTING: Médecins Sans Frontières (MSF) clinic in Mumbai, India.
OBJECTIVE: To determine the final treatment outcomes, culture conversion and adverse events (AEs) during treat...
OBJECTIVE: To determine the final treatment outcomes, culture conversion and adverse events (AEs) during treat...